HCPCS Level IIdrugActive
J7503
Tacrol envarsus ex rel oral
BETOS: O1E
Effective: 2019-01-01
Referenced in 1 policies
Description
Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Envarsus XR
Manufacturer
Veloxis Pharmaceuticals, Inc.
HCPCS Dosage
0.25 MG
Billing Units
400.0000
6
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.